Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Pediatric Pathology & Molecular Medicine|April 4, 2003
Stem cell transplantation for sickle cell disease: can we reduce the toxicity?J Fixler, E Vichinsky, M C WaltersExpert Opinion on Biological Therapy|October 20, 2006
The prevention and management of stroke in sickle cell anaemiaN Qureshi, B Lubin, M C WaltersPhysical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 7, 2014
Solidification in soft-core fluids: Disordered solids from fast solidification frontsA J Archer, M C Walters, U Thiele, et al.Physical Review. E|August 17, 2018
Structural crossover in a model fluid exhibiting two length scales: Repercussions for quasicrystal formationM C Walters, P Subramanian, A J Archer, et al.Cell|November 11, 1999
A functional enhancer suppresses silencing of a transgene and prevents its localization close to centrometric heterochromatinC Francastel, M C Walters, M Groudine, et al.Cancer Drug Delivery|January 1, 1985
Lack of dihydrofolate reductase in human tumor and leukemia cells in vivoB A Kamen, P A Nylen, V M Whitehead, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1983
Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidineH T Abelson, M T Fosburg, G P Beardsley, et al.Cancer Treatment Reports|January 1, 1981
Treatment of central nervous system tumors with methotrexateH T Abelson, D W Kufe, A T Skarin, et al.Cancer Chemotherapy and Pharmacology|December 1, 1982
Pharmacologic studies on the dibutyl and gamma-monobutyl esters of methotrexate in the rhesus monkeyA Rosowsky, H T Abelson, G P Beardsley, et al.National Cancer Institute Monograph|April 1, 1981
High-dose methotrexate in osteogenic sarcomaN Jaffe, M P Link, D Cohen, et al.Pageof 5